0413B |
Brodifacoum (Qualitative), Blood |
0413SP |
Brodifacoum (Qualitative), Serum/Plasma |
0414SP |
Bromadiolone (Qualitative), Serum/Plasma |
0420B |
Betahydroxybutyric Acid, Blood |
0420FL |
Betahydroxybutyric Acid, Fluid |
0500B |
Barbital, Blood |
0500SP |
Barbital, Serum/Plasma |
0500U |
Barbital, Urine |
0512B |
Barbiturates Screen, Blood |
0512SP |
Barbiturates Screen, Serum/Plasma |
0512U |
Barbiturates Screen, Urine |
0519B |
Barium, Blood |
0519H |
Barium, Hair |
0519SP |
Barium, Serum/Plasma |
0519TI |
Barium, Tissue |
0519U |
Barium, Urine |
0520B |
Belladonna Alkaloids Panel, Blood |
0520SP |
Belladonna Alkaloids Panel, Serum/Plasma |
0520U |
Belladonna Alkaloids Panel, Urine |
0541B |
Benzene, Blood |
0541TI |
Benzene, Tissue |
0542U |
Benzene Incident, Urine (OSHA) |
0543U |
Benzene OSHA Exposure Panel, Urine |
0556U |
Benzidine, Urine |
0560P |
Benzocaine, Plasma |
0560U |
Benzocaine, Urine |
0568B |
Benzodiazepines Screen, Blood |
0568FL |
Benzodiazepines Screen, Fluid |
0568SP |
Benzodiazepines Screen, Serum/Plasma |
0568U |
Benzodiazepines Screen, Urine |
0585B |
Benzonatate, Blood |
0585SP |
Benzonatate, Serum/Plasma |
0585U |
Benzonatate, Urine |
0610B |
Benzphetamine as Metabolites, Blood |
0610SP |
Benzphetamine as Metabolites, Serum/Plasma |
0610U |
Benzphetamine as Metabolites, Urine |
0620B |
Benztropine, Blood |
0620SP |
Benztropine, Serum/Plasma |
0620TI |
Benztropine, Tissue |
0620U |
Benztropine, Urine |
0630B |
Benzyl Alcohol, Blood |
0630SP |
Benzyl Alcohol, Serum/Plasma |
0638B |
Beryllium, Blood |
0638LI |
Beryllium, Liquid |
0638SP |
Beryllium, Serum/Plasma |
0638U |
Beryllium, Urine |
0642SP |
Betahydroxybutyric Acid, Serum/Plasma |
0642U |
Betahydroxybutyric Acid, Urine |
0645FL |
Bicarbonate, Fluid |
0645U |
Bicarbonate, Urine |
0680B |
Bismuth, Blood |
0680SP |
Bismuth, Serum/Plasma |
0680U |
Bismuth, Urine |
0690SP |
Bisphenol A - Free (Unconjugated), Serum/Plasma |
0690U |
Bisphenol A - Total (Conjugated/Unconjugated), Urine |
0711B |
Boron, Blood |
0711SP |
Boron, Serum/Plasma |
0711U |
Boron, Urine |
0716SP |
Brexpiprazole, Serum/Plasma |
0718B |
Brivaracetam, Blood |
0718SP |
Brivaracetam, Serum/Plasma |
0720B |
Bromine - Total, Blood |
0720SP |
Bromine - Total, Serum/Plasma |
0720U |
Bromine - Total, Urine |
0770B |
Brompheniramine, Blood |
0770SP |
Brompheniramine, Serum/Plasma |
0770U |
Brompheniramine, Urine |
0796B |
Bumetanide, Blood |
0796SP |
Bumetanide, Serum/Plasma |
0800B |
Bupivacaine, Blood |
0800FL |
Bupivacaine, Fluid |
0800SP |
Bupivacaine, Serum/Plasma |
0800U |
Bupivacaine, Urine |
0801B |
Buprenorphine and Metabolite - Free (Unconjugated), Blood |
0801ME |
Buprenorphine and Metabolite - Total (Conjugated/Unconjugated) (Qualitative), Meconium |
0801SP |
Buprenorphine and Metabolite - Free (Unconjugated), Serum/Plasma |
0801U |
Buprenorphine and Metabolite - Total (Conjugated/Unconjugated), Urine |
0802B |
Buprenorphine and Metabolite - Free (Unconjugated) Screen, Blood |
0802SP |
Buprenorphine and Metabolite - Free (Unconjugated) Screen, Serum/Plasma |
0802U |
Buprenorphine Screen, Urine |
0803B |
Bupropion and Metabolite, Blood |
0803FL |
Bupropion and Metabolite, Fluid |
0803SP |
Bupropion and Metabolite, Serum/Plasma |
0803TI |
Bupropion and Metabolite, Tissue |
0803U |
Bupropion and Metabolite, Urine |
0805B |
Buspirone, Blood |
0805SP |
Buspirone, Serum/Plasma |
0805U |
Buspirone, Urine |
0810B |
Butabarbital, Blood |
0810SP |
Butabarbital, Serum/Plasma |
0810U |
Butabarbital, Urine |
0820SP |
Busulfan, Serum/Plasma |
0830B |
Butalbital, Blood |
0830SP |
Butalbital, Serum/Plasma |
0830U |
Butalbital, Urine |
0835B |
Butane and Isobutane, Blood |
0850B |
Butanols, n-, iso-, Sec- and Tert, Blood |
0850SP |
Butanols, n-, iso-, Sec- and Tert, Serum/Plasma |
0850U |
Butanols, n-, iso-, Sec- and Tert, Urine |
0885B |
Butorphanol - Free (Unconjugated), Blood |
0885SP |
Butorphanol - Free (Unconjugated), Serum/Plasma |
0885U |
Butorphanol - Total (Conjugated/Unconjugated), Urine |
2111B |
Baclofen, Blood |
2111FL |
Baclofen, Fluid |
2111SP |
Baclofen, Serum/Plasma |
2111U |
Baclofen, Urine |
2626B |
Bath Salts Panel (Qualitative), Blood |
2626SP |
Bath Salts Panel (Qualitative), Serum/Plasma |
2626U |
Bath Salts Panel (Qualitative), Urine |
3227B |
Beta-Blockers Panel, Blood |
3227SP |
Beta-Blockers Panel, Serum/Plasma |
3227U |
Beta-Blockers Panel, Urine |
4127ME |
Buprenorphine and Metabolite - Total (Qualitative), Meconium |
6921H |
Barbiturates Screen, Hair |
6922H |
Benzodiazepines Screen, Hair |
8620B |
Barbiturates Panel, Blood |
8620FL |
Barbiturates Panel, Fluid |
8620ME |
Barbiturates Panel (Qualitative), Meconium |
8620SP |
Barbiturates Panel, Serum/Plasma |
8620TI |
Barbiturates Panel, Tissue |
8620U |
Barbiturates Panel, Urine |
8891OF |
Benzodiazepines Panel (Qualitative), Oral Fluid (Saliva) |
9118B |
Brompheniramine Screen, Blood |
9122B |
Bupropion and Metabolite Screen, Blood |
9122SP |
Bupropion and Metabolite Screen, Serum/Plasma |
9122TI |
Bupropion and Metabolite Screen, Tissue |
9122U |
Bupropion and Metabolite Screen, Urine |
9329B |
Benzodiazepines Panel, Blood |
9329FL |
Benzodiazepines Panel, Fluid |
9329ME |
Benzodiazepines Panel (Qualitative), Meconium |
9329SP |
Benzodiazepines Panel, Serum/Plasma |
9329TI |
Benzodiazepines Panel, Tissue |
9329U |
Benzodiazepines Panel, Urine |
9351UC |
Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |